2026 NPPES data Hematology & Oncology Physician NPI 1063457737 MD
Verify on CMS →

Dimitrios Diamandidis, MD

Hematology & Oncology Physician in Las Vegas, Nevada.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,232 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
545
Medicare Part D claims · 165 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
64%
generic claims · 36% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$205
4 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

Dimitrios Diamandidis, MD filed 545 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in Las Vegas, Nevada, prescribing 64% generic.

545
Part D claims, 2023
64%
generic prescribing
$205
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Dimitrios Diamandidis, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

545 Top 34% higher than 66% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic, not verified)

Dimitrios Diamandidis, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Dimitrios Diamandidis, MD?

Quality data not reported

NPI registry status

Active

Issued 06/18/2006

NPI 1063457737

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,232 US NPIs in this specialty

Medicare Part D claims

545 36% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in Nevada

How Hematology & Oncology Physician compares to other specialties among Nevada providers

Nevada providers
Personal Care Attendant25.1%Behavior Technician6.3%Rehabilitation Practitioner5.6%Behavior Analyst4.7%Chore Provider4.5%Mental Health Counselor2.6%Hematology & Oncology Physic…0.1%
Largest specialties in Nevada (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Dimitrios Diamandidis, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 2650 N TENAYA WAY STE 201, Las Vegas, NV, 89128, with a listed phone of (702) 240-0088. NPI 1063457737 was issued on 06/18/2006.

Medicare Part D records for calendar year 2023 show 545 prescription claims written by this provider, covering 165 Medicare beneficiaries and totaling roughly $908K in drug spend, split 36% brand-name and 64% generic by claim count, with an opioid prescribing rate of 16.7%.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,232 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2650 N TENAYA WAY STE 201
Las Vegas, NV 89128

Provider Details

NPI 1063457737
Specialty Hematology & Oncology Physician
Credentials MD
Gender Male
NPI Issued 06/18/2006

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Dimitrios Diamandidis, MD. Source: openpaymentsdata.cms.gov.

Total received

$205

Largest payer

Novartis Pharmaceuticals Corporation

Most common payment type

Long term medical supply or device loan

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

Dimitrios Diamandidis, MD - brand share 36.0%
Hematology & Oncology Physician average

36% brand-name claims vs 64% generic, on 545 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

545
Total Claims
$908K
Total Drug Cost
165
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
870
Total Day Supply
24,793
Brand vs Generic
36% brand / 64% generic
Brand Drug Cost
$763K
Generic Drug Cost
$146K
Opioid Claims
91 (16.7% rate)
Antibiotic Claims
14

Patient Demographics

Average Patient Age
72.4 years
Avg HCC Risk Score
2.16
Gender Split
68% female / 32% male
Age Distribution
<65: 17, 65-74: 83, 75-84: 49, 85+: 16

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Dimitrios Diamandidis, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Letrozole
95
Eliquis
Apixaban
74
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
35
Xarelto
Rivaroxaban
31
Xgeva
Denosumab
21
Anastrozole
17
Enoxaparin Sodium
16
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
14
Hydroxyurea
14
Oxycodone Hcl
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How Dimitrios Diamandidis, MD fits within the Hematology & Oncology Physician landscape nationally.

11,232
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

Dimitrios Diamandidis, MD's 545 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Nevada

Other clinicians with the same primary specialty enrolled in Nevada, drawn from the same CMS NPPES roster as Diamandidis.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Nevada medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Dimitrios Diamandidis, MD's specialty?
Dimitrios Diamandidis, MD specializes in Hematology & Oncology Physician and practices in Las Vegas, Nevada. Credentials: MD.
How much does Dimitrios Diamandidis, MD prescribe under Medicare Part D?
In 2023, Dimitrios Diamandidis, MD wrote 545 Medicare Part D claims totaling $908K in drug costs for 165 beneficiaries.
Where is Dimitrios Diamandidis, MD located?
Dimitrios Diamandidis, MD is located at 2650 N TENAYA WAY STE 201, Las Vegas, NV, 89128. Phone: (702) 240-0088.
What is Dimitrios Diamandidis, MD's NPI number?
Dimitrios Diamandidis, MD's National Provider Identifier (NPI) is 1063457737, issued on 06/18/2006.
Does Dimitrios Diamandidis, MD prescribe more brand-name or generic drugs?
Dimitrios Diamandidis, MD's prescribing is 36% brand-name and 64% generic drugs by claim count, with $763K in brand drug costs.
Does Dimitrios Diamandidis, MD prescribe opioids?
Yes, Dimitrios Diamandidis, MD had 91 opioid claims in 2023 with an opioid prescribing rate of 16.7%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,232 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Dimitrios Diamandidis, MD prescribe most often?
Based on 2023 Medicare Part D data, Dimitrios Diamandidis, MD's most frequently prescribed drugs include Letrozole, Eliquis, Oxycodone-Acetaminophen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Dimitrios Diamandidis, MD accept Medicare?
Dimitrios Diamandidis, MD appears in CMS Medicare data with 545 Part D claims and 165 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Dimitrios Diamandidis, MD's credentials?
Dimitrios Diamandidis, MD's NPI is 1063457737 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the editorial process.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.